Day: February 14, 2025

Digital Ally, Inc. Announces Closing of $15.0 Million Underwritten Public Offering

Written by Customer Service on February 14, 2025. Posted in Public Companies.

LENEXA, KS, Feb. 14, 2025 (GLOBE NEWSWIRE) — Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”), which develops, manufactures, and markets advanced video recording products and other critical safety products for a growing variety of industries and organizational functions, including law enforcement, emergency management, fleet safety and event security, today announced the closing of its previously announced firm commitment underwritten public offering. Gross proceeds to the Company were approximately $15.0 million, before deducting underwriting fees and other offering expenses payable by the Company. The offering closed on February 14, 2025. The offering consisted of 100,000,000 Common Units (or Pre-Funded Units), each consisting of (i) one (1) share of Common Stock or one (1) Pre-Funded Warrant, (ii) one (1) Series A Registered...

Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency

Written by Customer Service on February 14, 2025. Posted in Public Companies.

WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, shares a summary of the Company’s 2024 financing activity at the one year anniversary of being listed on the Nasdaq exchange.On October 29, Tevogen Bio signed a letter of intent with CD8 Technology Services to build an up to $50 million turn-key research and development facility for Tevogen Bio’s use. This arrangement, when finalized, will not dilute existing Tevogen Bio shareholders. On August 15, Tevogen Bio entered into a definitive agreement for a $6 million Series C Preferred Stock investment (“Series C”). The shares of the Series C have a 7.5% annual dividend and are convertible into shares of common stock after 6 months, at the election of the holder....

ITC bars importation of power modules and unlicensed computing systems that infringe Vicor patents

Written by Customer Service on February 14, 2025. Posted in Public Companies.

ANDOVER, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: VICR) today announced that, on February 13, the International Trade Commission (“ITC”) issued a Notice of Final Determination in its Investigation No. 337-TA-1370 (“In the Matter of Certain Power Converter Modules and Computing Systems Containing the Same”), confirming that Vicor U.S. Patent Nos. 9,516,761 (“’761 patent”) and 9,166,481 (“’481 patent”) are valid and infringed, and that unlicensed computing systems containing infringing power modules should be barred from importation into the United States. The ITC issued a Limited Exclusion Order against all Respondents and Cease and Desist Orders against Respondents Delta Electronics (Americas) Ltd., Quanta Computer USA Inc. and Quanta Computer Inc., FII USA Inc., and Ingrasys Technology USA Inc. Following...

Southern Michigan Bancorp, Inc. Announces Fourth Quarter and Full Year 2024 Earnings

Written by Customer Service on February 14, 2025. Posted in Public Companies.

COLDWATER, Mich., Feb. 14, 2025 (GLOBE NEWSWIRE) — Southern Michigan Bancorp, Inc. (OTC Pink: SOMC) announced fourth quarter net income of $2,650,000, or $0.57 per share, compared to net income of $2,437,000, or $0.54 per share, for the fourth quarter of 2023. Southern earned $10,402,000 or $2.28 per share, for the year ended December 31, 2024, compared with $10,905,000 or $2.40 per share, for the same period one year ago. John R. Waldron, President and Chief Executive Officer of Southern Michigan Bancorp, Inc., stated, “2024 was another solid year with total assets reaching approximately $1.5 billion. During the year ended December 31, 2024, total loans and deposits grew to $1.116 billion and $1.252 billion, respectively. While our earnings continue to be impacted by the current interest rate environment, we remain encouraged...

THEON announces FY 2024 preliminary results above guidance, highlighting robust performance throughout the year, and anticipating further strong growth in FY 2025

Written by Customer Service on February 14, 2025. Posted in Earnings Releases And Operating Results.

Press ReleaseBloomberg (THEON:NA) / Reuters (THEON.AS)Order intake of €466 million, resulting in a soft backlog of €654 million, marking a 20% year-on-year increase Additional embedded options of €301 million, providing further visibility Revenue of €352.4 million, above guidance, representing top line growth of 61.1% Adjusted EBIT of €88.2 million, maintaining best-in-class margin of 25.0% Net Cash position of €41.9 million, enabling execution of both organic and inorganic growth strategy Reiterated FY 2025 guidance, with revenue expected in the range €410 – 430 million, targeting a continuing mid-twenties EBIT marginNicosia, 14 February 2025 – Theon International Plc (THEON) is today announcing preliminary results for FY 2024, demonstrating a very strong performance, with FY 2025 guidance signposting continued strong growth....

Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity

Written by Customer Service on February 14, 2025. Posted in Public Companies.

WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, today issued a statement from its Founder and CEO, Nobel Peace Prize nominee Dr. Ryan Saadi, regarding broader implications of short-selling. “Tevogen Bio is committed to advancing innovative medical solutions while maintaining affordability for patients, a mission that is essential for sustainable healthcare innovation. Since going public, we have made significant progress, including a collaboration between Tevogen.AI and Microsoft (Nasdaq: MSFT) to explore AI applications in biotechnology. Despite these advancements, our share price has faced pressure,” said Dr. Ryan Saadi, Founder & CEO of Tevogen Bio. “This brings into question the indirect impact...

STEALTHGAS INC. Announces the Date for the Release of the Fourth Quarter and Twelve Months 2024 Financial and Operating Results, Conference Call and Webcast

Written by Customer Service on February 14, 2025. Posted in Earnings Releases And Operating Results.

ATHENS, Greece, Feb. 14, 2025 (GLOBE NEWSWIRE) — STEALTHGAS INC. (NASDAQ: GASS) (the “Company”), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today that it will release its fourth quarter operating and financial results for the period ended December 31, 2024 before the market opens in New York on February 21, 2025. On February 21, 2025 at 10:00 am ET, the company’s management will host a conference call to discuss the results and the company’s operations and outlook. Conference Call details: Conference call participants should pre-register using the below link to receive the dial-in numbers and a personal PIN, which are required to access the conference call. Online Registration: https://register.vevent.com/register/BIa607c71e1abf4ac08816dfc43bd8d733 Slides...

SANOMA CORPORATION: ACQUISITION OF OWN SHARES 14 February 2025

Written by Customer Service on February 14, 2025. Posted in Public Companies.

Sanoma Corporation, Stock exchange release, 14 February 2025 at 18:30 EET SANOMA CORPORATION: ACQUISITION OF OWN SHARES 14 February 2025 Nasdaq Helsinki Ltd:Date 14 February 2025 Exchange transaction Buy Share class SANOMA Amount 3,024 Average price/share, EUR 8.6758 Highest price/share, EUR 8.7300 Lowest price/share, EUR 8.6400 Total cost, EUR 26,235.62 The share buybacks are executed in compliance with Regulation No. 596/2014 of the European Parliament and Council (MAR) Article 5 and the Commission Delegated Regulation (EU) 2016/1052. The company holds a total of 489,826 of its own shares (SANOMA) including the shares acquired on 14 February 2025. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Sanoma Corporation Skandinaviska...

Cygnus Starts Trading on OTCQB Market

Written by Customer Service on February 14, 2025. Posted in Public Companies.

HIGHLIGHTS:Cygnus’ common shares have qualified to trade on the OTCQB® Venture Market (“OTCQB”), a U.S. marketplace operated by OTC Markets Group Inc. (the “OTC”), Trading commences today under the ticker “CYGGF”TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) — Cygnus Metals Limited (ASX: CY5; TSXV: CYG; OTCQB: CYGGF) (“Cygnus” or the “Company”) is pleased to announce that its common shares have qualified to trade on the OTCQB® Venture Market (“OTCQB”), a U.S. marketplace operated by OTC Markets Group Inc. (the “OTC”), and will commence trading today under the symbol “CYGGF”. The common shares of the Company will continue to trade on the ASX and TSX Venture Exchange. Cygnus Executive Chair David Southam said: “Given the strong outlook for copper, it is an ideal...

Invesco Ltd: Form 8.3 -Dowlais Group PLC; Public dealing disclosure

Written by Customer Service on February 14, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION (a) Full name of discloser: Invesco Ltd. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Dowlais Group plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

Day: February 14, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals